News

InvestorsHub on MSN1d
Abbott Upgraded by Jefferies as Stock Selloff Seen as Overreaction
Abbott Laboratories (NYSE:ABT) received an upgrade from Jefferies, which raised its rating to Buy from Hold, stating that the ...
Should You Buy Abbott Stock At $135?
Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...
Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021.
Abbott Laboratories stock tumbled Thursday after the maker of medical devices and nutrition products narrowed its full-year ...
P/E Ratio Insights for Abbott Laboratories
Abbott Laboratories has a lower P/E than the aggregate P/E of 53.67 of the Health Care Equipment & Supplies industry. Ideally ...
Abbott upgraded after post-earnings selloff, hardware drag seen temporary
Investing.com -- Jefferies upgraded Abbott Laboratories (NYSE: ABT) to Buy from Hold, calling the market reaction to the ...
Nasdaq8mon
What Are Wall Street Analysts' Target Price for Abbott Laboratories ...
Abbott Laboratories stock rose 1.5% on Oct. 16 due to its strong Q3 earnings, where adjusted EPS of $1.21 beat estimates, reflecting a 6.1% increase from last year.
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...
Abbott Laboratories CEO calls post-earnings stock decline ‘a little bit of an overreaction'
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
Nasdaq3mon
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know ... - Nasdaq
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It March 24, 2025 — 09:00 am EDT Written by Zacks Equity Research for Zacks -> ...